What's in AlgoRx Pharmaceuticals's pipeline?

AlgoRx Pharmaceuticals has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with AlgoRx Pharmaceuticals's portfolio?

Top competitors by shared drug class: Ritter Pharmaceuticals, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/algorx-pharmaceuticals.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

AlgoRx Pharmaceuticals — Portfolio Competitive Intelligence Brief

AlgoRx Pharmaceuticals pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ALGRX 3268	ALGRX 3268	phase 3	Microbiome modulator	Alginate lyase	Gastroenterology / Immunology

Therapeutic area mix

Gastroenterology / Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ritter Pharmaceuticals, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for AlgoRx Pharmaceuticals:

Cite this brief

Drug Landscape (2026). AlgoRx Pharmaceuticals — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/algorx-pharmaceuticals. Accessed 2026-05-15.